August 7th 2022, 4:00pm
Alzheimer's Association International Conference
The chief medical officer and cofounder of Linus Health provided insight on the outlook of acoustic measures and machine learning to further classify cognitive impairment. [WATCH TIME: 4 minutes]
August 7th 2022, 9:00am
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is neuromyelitis optica spectrum disorder.
August 6th 2022, 3:00pm
Jagan A. Pillai, MD, PhD, neurologist, Cleveland Clinic Lou Ruvo Center for Brain Health, discussed a recent study which found faster clinical progression in those with nonamnestic initial cognitive symptoms.
August 5th 2022, 3:00pm
Alzheimer's Association International Conference
Effect modification by cognitive status and APOE genotype revealed greater effects of mild behavioral impairment with apathy in those who had normal cognition or in non-APOE ɛ4 groups.
August 4th 2022, 3:00pm
Inflammatory coagulation pathway activator positive extracellular vesicles were significantly increased in women with a history of severe preeclampsia compared with controls and those with milder cases.
August 4th 2022, 1:00pm
The neurologist at Cleveland Clinic’s Lou Ruvo Center for Brain Health detailed new findings on whether initial cognitive symptoms have similar rates of functional decline across a handful of neurodegenerative disorders. [WATCH TIME: 3 minutes]
August 4th 2022, 11:00am
Alzheimer's Association International Conference
In addition to significant associations between executive memory and cognition, baseline neurofilament light levels and age trended toward significance.
August 3rd 2022, 9:00pm
Alzheimer's Association International Conference
The chief medical officer and cofounder of Linus Health provided background on the reasoning for the measures used in a new machine learning algorithm that classifies cognitive status. [WATCH TIME: 3 minutes]
August 3rd 2022, 7:00pm
Alzheimer's Association International Conference
During a Focused Topic Session at the 2022 Alzheimer’s Association International Conference, NeurologyLive® inquired with a panel of experts about the possibility of exploring a combination approach to Alzheimer disease as the future of treatment.
August 3rd 2022, 3:00pm
Alzheimer's Association International Conference
All severities of Alzheimer disease showed statistically significant benefits from the exercise program relative to controls, with more mild groups demonstrating the most improvement.
Incorporating Voice Analytics Into Cognitive Assessments: Alvaro Pascual-Leone, MD, PhD
NeurologyLive® Brain Games: August 7, 2022
Getting Up to Speed on the Evolving Landscape of Multiple Sclerosis: Annette Okai, MD
Using Initial Cognitive Symptoms to Predict Trajectories of Neurodegenerative Pathologies